The artificial tendons and ligaments market is projected to grow at a CAGR of 13.6% during the forecast period.
By application, the knee injuries segment is expected to grow at the highest rate during the forecast period.
Based on application, the market is segmented into knee injuries, shoulder injuries, foot and ankle injuries, and other injuries (spine and hip injuries). The knee injuries segment is expected to grow at the highest CAGR during the forecast period. This can be attributed to the increasing incidence of knee injuries, discomfort at the harvest site due to conventional surgical treatment methods that use autografts and allografts, rising participation in sports, and advantages of artificial tendons and ligaments as compared to autografts and allografts.
The Asia Pacific artificial tendons and ligaments market is expected to grow at the highest CAGR during the forecast period.
Asia Pacific is expected to witness the highest growth during 2018 to 2023, owing to Japan’s growing healthcare industry, collaborations with various international sports organizations, research activities in sports medicine, government initiatives to increase the number of doctors, favorable tax policy in China, government initiatives to support sports medicine in India, funding initiatives and grants to promote sports in Australia, favorable healthcare system, and focus of LARS in Australia, and focus on sports medicine in Malaysia and Singapore.
Break of primary participants was as mentioned below:
- By Company Type – Tier 1–55%, Tier 2–25% and Tier 3–20%
- By Designation – C-level–43%, Director Level–32%, Others–25%
- By Region – Europe–38%, North America–23%, Asia Pacific–29%, RoW–10%
The key players in the global artificial tendons and ligaments market are LARS (France), Neoligaments (UK), Cousin Biotech (France), Orthomed S.A.S. (France), FX Solutions (France), Shanghai PINE&POWER Biotech (China), and Mathys AG Bettlach (Switzerland).
Research Coverage:
The report analyzes the artificial tendons and ligaments market and aims at estimating the market size and future growth potential of this market based on various segments such as application and region. It provides detailed information regarding the major factors influencing the growth of this market and the regulatory analysis impacting market dynamics.
Reasons to Buy the Report
The report can help established firms as well as new entrants/smaller firms to gauge the pulse of the market, which in turn would help them garner a greater share. Firms purchasing the report could use one or any combination of the below mentioned three strategies.
This report provides insights into the following pointers:
- Product Development/Innovation: Detailed insights on upcoming technologies, research and development activities, and product launches in the artificial tendons and ligaments market
- Market Development: Comprehensive information about lucrative emerging markets. The report analyzes the markets for various artificial tendons and ligaments across regions
- Market Diversification: Exhaustive information about products, untapped regions, recent developments, and investments in the artificial tendons and ligaments market
Table of Contents
Companies Mentioned
- Lars
- Neoligaments (A Division of Xiros)
- Cousin Biotech
- FX Solutions
- Orthomed
- Shanghai Pine&Power Biotech
- Mathys
Table Information
Report Attribute | Details |
---|---|
No. of Pages | 94 |
Published | July 2018 |
Forecast Period | 2018 - 2023 |
Estimated Market Value ( USD | $ 18.5 million |
Forecasted Market Value ( USD | $ 35 million |
Compound Annual Growth Rate | 13.6% |
Regions Covered | Global |
No. of Companies Mentioned | 7 |